| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Amrubicin monotherapy for patients with extrapulmonary neuroendocrine carcinoma after platinum-based chemotherapy
|
Nio, Kenta
|
|
2015
|
75 |
4 |
p. 829-835
|
artikel
|
| 2 |
A pharmacokinetic binding model for bevacizumab and VEGF165 in colorectal cancer patients
|
Panoilia, Eirini
|
|
2015
|
75 |
4 |
p. 791-803
|
artikel
|
| 3 |
A randomized, crossover phase 1 study to assess the effects of formulation (capsule vs tablet) and meal consumption on the bioavailability of dovitinib (TKI258)
|
Infante, Jeffrey R.
|
|
2015
|
75 |
4 |
p. 729-737
|
artikel
|
| 4 |
A randomized study of cisplatin and 5-FU hepatic arterial infusion chemotherapy with or without adriamycin for advanced hepatocellular carcinoma
|
Song, Myeong Jun
|
|
2015
|
75 |
4 |
p. 739-746
|
artikel
|
| 5 |
Biological evaluation of 4,5-diarylimidazoles with hydroxamic acid appendages as novel dual mode anticancer agents
|
Mahal, Katharina
|
|
2015
|
75 |
4 |
p. 691-700
|
artikel
|
| 6 |
Cisplatin in combination with metronomic vinorelbine as front-line treatment in advanced non-small cell lung cancer: a multicenter phase II study of the Hellenic Oncology Research Group (HORG)
|
Katsaounis, P.
|
|
2015
|
75 |
4 |
p. 821-827
|
artikel
|
| 7 |
Comparative pharmacokinetic properties and antitumor activity of the marine HDACi Largazole and Largazole peptide isostere
|
Pilon, John L.
|
|
2015
|
75 |
4 |
p. 671-682
|
artikel
|
| 8 |
Delayed methotrexate excretion in infants and young children with central nervous system tumors and postoperative fluid collections
|
Cohen, Ian
|
|
2015
|
75 |
4 |
p. 875
|
artikel
|
| 9 |
Gemcitabine, oxaliplatin, and capecitabine (GEMOXEL) compared with gemcitabine alone in metastatic pancreatic cancer: a randomized phase II study
|
Petrioli, Roberto
|
|
2015
|
75 |
4 |
p. 683-690
|
artikel
|
| 10 |
Germline TYMS genotype is highly predictive in patients with metastatic gastrointestinal malignancies receiving capecitabine-based chemotherapy
|
Joerger, M.
|
|
2015
|
75 |
4 |
p. 763-772
|
artikel
|
| 11 |
Hepatitis B virus reactivation and hepatitis in gastrointestinal cancer patients after chemotherapy
|
Yang, Yu
|
|
2015
|
75 |
4 |
p. 783-790
|
artikel
|
| 12 |
Open-label phase 1b study of FOLFIRI plus cetuximab plus IMO-2055 in patients with colorectal cancer who have progressed following chemotherapy for advanced or metastatic disease
|
Chan, Emily
|
|
2015
|
75 |
4 |
p. 701-709
|
artikel
|
| 13 |
Overview of neuropathy associated with taxanes for the treatment of metastatic breast cancer
|
Rivera, Edgardo
|
|
2015
|
75 |
4 |
p. 659-670
|
artikel
|
| 14 |
Parallel phase Ib studies of two schedules of buparlisib (BKM120) plus carboplatin and paclitaxel (q21 days or q28 days) for patients with advanced solid tumors
|
Hyman, David M.
|
|
2015
|
75 |
4 |
p. 747-755
|
artikel
|
| 15 |
Phase II study of gemcitabine and S-1 combination chemotherapy in patients with metastatic biliary tract cancer
|
Kim, Hyeong Su
|
|
2015
|
75 |
4 |
p. 711-718
|
artikel
|
| 16 |
Phase II study of mFOLFOX3 (5-fluorouracil, leucovorin, oxaliplatin) as second-line treatment after gemcitabine failure in patients with unresectable/metastatic biliary tract cancer
|
Hwang, In Gyu
|
|
2015
|
75 |
4 |
p. 757-762
|
artikel
|
| 17 |
Phase I trial of oral S-1 combined with hepatic arterial infusion of gemcitabine in unresectable biliary tract cancer
|
Ishiwatari, Hirotoshi
|
|
2015
|
75 |
4 |
p. 805-812
|
artikel
|
| 18 |
Phase I trial of valproic acid and lenalidomide in patients with advanced cancer
|
Bilen, Mehmet Asim
|
|
2015
|
75 |
4 |
p. 869-874
|
artikel
|
| 19 |
Preclinical pharmacokinetics, pharmacodynamics, and efficacy of RG7116: a novel humanized, glycoengineered anti-HER3 antibody
|
Meneses-Lorente, Georgina
|
|
2015
|
75 |
4 |
p. 837-850
|
artikel
|
| 20 |
Prognostic value of ERCC1, RRM1, and TS proteins in patients with resected non-small cell lung cancer
|
He, Yu-Wen
|
|
2015
|
75 |
4 |
p. 861-867
|
artikel
|
| 21 |
Response to: comment on “Delayed methotrexate excretion in infants and young children with primary central nervous system tumors and postoperative fluid collections”
|
Wright, Karen D.
|
|
2015
|
75 |
4 |
p. 877-878
|
artikel
|
| 22 |
Safety, pharmacokinetics, and pharmacodynamic properties of oral DEBIO1143 (AT-406) in patients with advanced cancer: results of a first-in-man study
|
Hurwitz, Herbert I.
|
|
2015
|
75 |
4 |
p. 851-859
|
artikel
|
| 23 |
Serum metallothionein in patients with testicular cancer
|
Tariba, Blanka
|
|
2015
|
75 |
4 |
p. 813-820
|
artikel
|
| 24 |
Stabilization of the Karenitecin® lactone by alpha-1 acid glycoprotein
|
Yao, Shijie
|
|
2015
|
75 |
4 |
p. 719-728
|
artikel
|
| 25 |
Synthesis and biological evaluation of geldanamycin analogs against human cancer cells
|
Li, Yan-ping
|
|
2015
|
75 |
4 |
p. 773-782
|
artikel
|
Tijdschrift beschrijving